Search the Newsreel

Lobbying Update: $80,000 of UNITED THERAPEUTICS CORPORATION lobbying was just disclosed

A recent Lobbying Disclosure Act filing revealed that UNITED THERAPEUTICS CORPORATION disclosed $80,000 in lobbying expenditures for Q2 2026, primarily concerning "Issues related to organs and xenotransplantation." The article also details significant insider selling activity, with various executives selling millions of dollars worth of …

United Therapeutics Corp (UTHR)

This article provides a brief overview of United Therapeutics Corp (UTHR) stock performance and key financial metrics. It includes current stock price, daily and 52-week ranges, open and close prices, average volume, market capitalization, shares outstanding, EPS, and P/E ratio.

United Therapeutics (UTHR) Stock Still Looks Like A Bargain After A 185% Run

United Therapeutics (UTHR) has seen its stock rise by 185% over five years, yet analysis suggests it remains undervalued, trading below its fair P/E and peer group average. Recent FDA approval for LungFX and positive phase 3 data for nebulized Tyvaso contribute to a …

Form 4 United Therapeutics Corporation For: 16 July By Investing.com

This article reports on a Form 4 filing for United Therapeutics Corporation (UTHR) for activity on July 16. It notes that UTHR stock experienced a slight decrease of 0.52%. The filing information is presented without further commentary or detailed financial analysis.

United Therapeutics CEO Rothblatt sells $5.04m in UTHR shares

Martine A. Rothblatt, CEO of United Therapeutics Corp (NASDAQ:UTHR), sold approximately $5.04 million worth of company shares on July 15, 2026, as part of a pre-arranged 10b5-1 trading plan. Prior to the sale, she acquired 9,500 shares through stock option exercises. The transactions occurred …

Q1 Earnings Outperformers: United Therapeutics (NASDAQ:UTHR) And The Rest Of The Therapeutics Stocks

Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report?

We Like The Quality Of Genting Plantations Berhad's (KLSE:GENP) Earnings

UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong Outlook

SD Guthrie Malaysia 1st-Quarter 2026 Earnings Summary Table

United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings

Investors Shouldn't Be Too Comfortable With SD Guthrie Berhad's (KLSE:SDG) Earnings

United Therapeutics (UTHR) to Report Q1 Results: Wall Street Expects Earnings Growth

United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?

SD Guthrie Berhad (KLSE:SDG) stock performs better than its underlying earnings growth over last three years

SD Guthrie Berhad Appoints Dato' Mohd Nizam Zainordin as Non Independent and Non Executive Member of Risk Committee

SD Guthrie Berhad (5285.KL) stock price, news, quote and history